Apr. 30, 2020—A new clinic opening at Vanderbilt University Medical Center will help doctors and patients choose the best drugs for their medical conditions based on the patients’ unique genetic makeup.
Apr. 30, 2020—A new technique shows the potential to increase the supply of donor lungs by rehabilitating those organs previously considered too damaged for transplant.
Apr. 29, 2020—Two Drug Detection Canines (DDC) are now reporting for duty in the halls and units of the Vanderbilt University Adult Hospital (VUAH).
Apr. 23, 2020—The rapid ramping up of SARS-CoV-2 testing at VUMC reflects the dedication of the professionals who work in the Clinical Laboratory and also their collaboration with colleagues in research laboratories throughout VUMC.
Apr. 23, 2020—Compared to last April, through April 19 the adult trauma service at Vanderbilt University Medical Center is on track to admit 65% fewer patients from roadway accidents, including motor vehicle accidents, motorcycle accidents and pedestrians struck by autos.
Apr. 22, 2020—What do you do with 154 nursing students who are suddenly unable to participate in the hands-on nursing (clinical) care that makes up 60% of their education each week?
Apr. 16, 2020—Stop by the Courtyard Café at Vanderbilt University Adult Hospital and you’ll see that COVID-19 has wrought some obvious changes.
Apr. 16, 2020—The Medical Scientist Training Program has been intentional in approaching the challenges presented by COVID-19.
Apr. 9, 2020—A group of physicians, nurses and representatives from multiple areas throughout VUMC came up with a process in less than a week to safely and effectively sanitize used N95 respirators.
Apr. 9, 2020—The NCI program project grant is supporting multiple projects that aim to define fundamental biological principles about extracellular RNA signaling and the development and aggressiveness of colorectal cancer, the second leading cause of cancer death in the United States.
Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments
Apr. 8, 2020—Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.